Journal
JOURNAL OF AFFECTIVE DISORDERS
Volume 155, Issue -, Pages 216-222Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2013.11.003
Keywords
Depression; Percutaneous coronary intervention; Saffron; Crocus sativus L; Clinical trial
Categories
Funding
- Tehran University of Medical Sciences [16074]
Ask authors/readers for more resources
Objective: A significant correlation exists between coronary artery diseases and depression. The aim of this trial was to compare the efficacy and safety of saffron versus fluoxetine in improving depressive symptoms of patients who were suffering from depression after performing percutaneous coronary intervention (PCl). Methods: In this randomized double-blind parallel group study, 40 patients with a diagnosis of mild to moderate depression who had undergone PCl in the last six months were randomized to receive either fluoexetine (40 mg/day) or saffron (30 mg/day) capsule for six weeks. Participants were evaluated by Hamilton depression rating scale (HORS) at weeks 3 and 6 and the adverse events were systemically recorded. Results: By the study endpoint, no significant difference was detected between two groups in reduction of HORS scores (P=0.62). Remission and response rates were not significantly different as well (P=1.00 and P=0.67; respectively). There was no significant difference between two groups in the frequency of adverse events during this trial. Limitations: Relatively small sample size and short observational period were the major limitations of this study. Conclusion: Short-term therapy with saffron capsules showed the same antidepressant efficacy compared with fluoxetine in patients with a prior history of PCf who were suffering from depression. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available